The US has hit another milestone of coronavirus. As of Sunday morning, COVID-19 had infected 5,017,150 people in the US. It killed 727,984 people worldwide and 162,555 in the U.S., and also infected at least 19.7 million people worldwide, according to the Center for Systems Science and Engineering at Johns …
Read More »With U.S. infections close to 5 million, Fauci says public expectations should temper COVID-19 vaccine
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases for the last three decades and an expert on pandemics for the last four decades, has been optimistic about a vaccine arriving in late 2020 or early 2021, but he has also warned the public about their expectations …
Read More »AstraZeneca reports strong gains and progress from the vaccine. The stock is going up.
Text size fake pictures Shares of AstraZeneca rose on Thursday as new drug sales helped the British pharmaceutical giant exceed expectations in the second quarter. Late-stage trials for its experimental coronavirus vaccine, developed with the University of Oxford, have also begun in the UK, Brazil and South Africa, the company …
Read More »Johnson & Johnson begins trial of one-dose Covid-19 vaccine
Text size Johnson & Johnson became the third western biopharmaceutical company to start a new test of its Covid-19 vaccine this week, but with one difference: in a surprise announcement Thursday morning, the company said it would test its vaccine in a format single dose. Moderna (MRNA) and Pfizer (PFE) …
Read More »Pfizer shares rise after earnings. Here’s why stocks rose more.
Text size Spencer Platt / Getty Images Large pharmaceutical company Pfizer announced second-quarter financial results on Tuesday morning that exceeded Wall Street expectations, sending shares of around 3% in pre-trade. The company reported earnings of $ 0.78 per share, beating the FactSet consensus at $ 0.10 and the S&P Capital …
Read More »